483
NATCO Pharma LimitedNATCO Pharma Limited – FDA 483, Jun 5, 2019
Record Details
An FDA inspection of NATCO Pharma Limited, a sterile and non-sterile finished drug manufacturer in Rangareddy, India, revealed significant deficiencies across multiple systems. The firm failed to adhere to quality control unit responsibilities, maintain adequate laboratory controls, follow written procedures for annual product reviews and investigations, and ensure proper equipment calibration. These issues indicate a systemic lack of compliance with cGMP regulations.
View Company Profile
ID · 0bf5ef08-8bd5-4fcd-a591-64b19920b76d
Other documents for NATCO Pharma Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.